Nedd9 restrains autophagy to limit growth of early stage non-small cell lung cancer

Non-small cell lung cancer (NSCLC) is the most common cancer worldwide. With overall 5-year survival estimated at <17%, it is critical to identify factors that regulate NSCLC disease prognosis. NSCLC is commonly driven by mutations in KRAS and TP53, with activation of additional kinases such as S...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Cancer Res
Main Authors: Deneka, Alexander Y., Kopp, Meghan C., Nikonova, Anna S., Gaponova, Anna V., Kiseleva, Anna A., Hensley, Harvey H., Flieder, Douglas B., Serebriiskii, Ilya G., Golemis, Erica A.
Format: Artigo
Jezik:Inglês
Izdano: 2021
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC8277748/
https://ncbi.nlm.nih.gov/pubmed/34006524
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-20-3626
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki